fda halts glp-1 What Changed? The FDA's Clarification on Compounded Drugs FDA crackdown halts GLP-1 production

There are relatively high levels of obesity in various Asian markets, averaging at an overall 20% or so, NielsenIQ Regional Executive Director Craig Houliston told us

We don't know what happens when you are suppressing weight for these kids at a time when they're supposed to be growing

Concurrently, recent reports have raised concerns regarding possible ED development among GLP-1 RA users

Ethical and feasibility concerns also limit the design of such trialsfor instance, it may not be justifiable to randomize patients to specific agents solely to assess safety outcomes, especially when some newer agents offer established cardiovascular and renal benefits

The practical reason to read "Noom Med vs Calibrate: GLP-1 + Coaching Programs Compared" is to separate useful context from easy claims about cost and coverage, safety and pharmacy quality